arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ

$0.93 ▼ -0.17 (-15.42%) at close

17 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth -45.5% ↘

Op. Margin —

ROIC -81.7% ↗

FCF / Share None

Trailing P/E —

Price / Book 0.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 22, 2026.

17-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$6.00K

↓ -45.5% —

Net Income Profit after all expenses

$-6.00M

↓ -9.1% —

FCF / Share Free cash flow per share

$-0.71

↑ +16.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue Growth YoY (%)	-45.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-668%)	22.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+178%)	-89.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1223%)	1.0% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-88%)	-46.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-683%)	-0.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-108%)	33.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+313%)	2491.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+31046%)	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-9.1% Weak ↓ Weak Declining Year-over-year change in net income	-3.9% Weak Weak Year-over-year change in net income	47.9% Excellent Excellent Year-over-year change in net income	N/M	N/M	-328.2% Weak ↓ Weak Declining Year-over-year change in net income	37.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-413.5% Weak ↑ Weak Improving Year-over-year change in net income	-247.1% Weak ↑ Weak Improving Year-over-year change in net income	-2390.4% Weak ↓ Weak Declining Year-over-year change in net income	-9.8% Weak ↓ Weak Declining Year-over-year change in net income	-2.7% Weak ↑ Weak Improving Year-over-year change in net income	-6.6% Weak ↑ Weak Improving Year-over-year change in net income	-6.4% Weak Weak Year-over-year change in net income	-39.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	—	—	—	16.1% Good Good Year-over-year change in free cash flow	-13.4% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	15.5% Good ↑ Good Improving Year-over-year change in free cash flow	24.4% Good Good Year-over-year change in free cash flow	-36.6% Weak Weak Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	-59.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-50.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-62.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-18.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-11.0% Weak Weak Compound annual revenue growth over 3 years	224.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-48.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-41.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-40.9% Weak Weak Compound annual revenue growth over 5 years	79.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	-264.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.98x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.52x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.12x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.01x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.14x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.08x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.33x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Return on Invested Capital (%)	-81.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-90.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-54.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-64.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-30.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	14.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	27.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	52.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	380.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	9.0% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	10.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	12.7% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	16.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	21.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	23.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-78.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-86.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-52.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-53.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-155.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-212.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-233.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-579.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-235.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9644.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2036.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5379.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1281.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-638.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-3451.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-79.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-632%)	-86.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-678%)	-51.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-441%)	-63.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-526%)	188.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1153%)	91.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+508%)	105.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+601%)	—	118.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+693%)	—	16.7% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+12%)	18.3% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+22%)	21.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+45%)	26.2% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+74%)	33.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+122%)	35.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+139%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Interest Coverage (x)	—	—	—	—	-0.73x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-0.91x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-0.60x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-0.82x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.12x Weak Weak Operating income divided by interest expense Optimal: > 5x	-118.74x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	—	—	—	—	$-10.72M	$-98.01K	$-88.65K	$-304.06K	$-13.70K	$-221.87K	$-216.00	$-954.00	$-374.00	$-781.00	$-1.10K	$-414.00	$-575.00

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue per Share (USD)	—	—	—	$0.01	$0.03	$0.28	—	—	—	—	$0.00	$0.00	$0.00	$0.00	—	—	—
Basic EPS, GAAP (USD)	—	—	—	$-0.93	$7.37	$-62.69	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	—	—	$-0.71	$-0.85	$-0.75	—	—	—	—	$-0.00	$-0.00	$-0.00	$-0.00	—	—	—
Book Value per Share (USD)	$2.03	$3.63	$7.53	$1.13	$1.61	$-25.90	$-0.36	$-0.66	$-0.02	$-0.00	$-0.01	$-0.01	$-0.01	$-0.01	$-0.00	$-0.00	—
Tangible Book Value per Share (USD)	$2.03	$3.63	$7.53	$1.13	$1.61	$-25.90	$-0.36	$-0.66	$-0.02	$-0.00	$-0.01	$-0.01	$-0.01	$-0.01	$-0.00	$-0.00	—
Basic Weighted Avg Shares (shares)	—	—	—	10.93M	2.61M	579,461	—	—	—	—	18.11M	18.11M	18.11M	18.11M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Working Capital (USD)	$7.11M	$5.81M	$9.90M	$15.43M	$9.69M	$-40.42M	$-8.51M	$-4.16M	$-2.42M	$-232.00K	$-157.60K	$-153.04K	$-125.03K	$-97.75K	$-72.16K	$-48.11K	—
Total Equity (USD)	$7.51M	$6.34M	$10.34M	$15.86M	$10.22M	$-39.80M	$-8.07M	$-3.99M	$-2.24M	$-157.79K	$-183.80K	$-153.04K	$-125.03K	$-97.75K	$-72.16K	$-48.11K	—

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	$6.00K	$11.00K	$9.00K	$88.60K	$87.75K	$164.50K	$165.50K	$124.40K	$4.80K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—
Net Income, GAAP (USD)	$-6.00M	$-5.49M	$-5.29M	$-10.14M	$19.21M	$-36.33M	$-8.48M	$-13.66M	$-2.66M	$-766.07K	$-30.76K	$-28.01K	$-27.28K	$-25.59K	$-24.05K	$-17.26K	—
Operating Cash Flow (USD)	$-5.86M	$-5.30M	$-8.03M	$-7.80M	$-2.22M	$-434.56K	$-1.21M	$-1.05M	$-889.62K	$-445.23K	$-14.64K	$-17.32K	$-22.91K	$-16.77K	$-13.96K	$-13.66K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 66 quarters

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

Analytical Summary

17-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CELZ with peers